Patent assignee · US · COMPANY

TargeGen, Inc.

13Patents

12Active

13Granted

48Portfolio score

Filing activity: Oct 2, 2003 → Sep 23, 2011 · 11 expiring within 5 years

Most-cited patents

Patent	Title	Area	Cited by	Status
US7528143B2	Bi-aryl meta-pyrimidine inhibitors of kinases	Chemistry; Metallurgy	176	Active
US8133900B2	Use of bi-aryl meta-pyrimidine inhibitors of kinases	Chemistry; Metallurgy	90	Active
US7208493B2	Vasculostatic agents and methods of use thereof	Chemistry; Metallurgy	47	Expired
US8138199B2	Use of bi-aryl meta-pyrimidine inhibitors of kinases	Chemistry; Metallurgy	39	Active
US7825246B2	Bi-aryl meta-pyrimidine inhibitors of kinases	Chemistry; Metallurgy	33	Active
US8604042B2	Bi-aryl meta-pyrimidine inhibitors of kinases	Chemistry; Metallurgy	26	Active
US8030487B2	2-amino—5-substituted pyrimidine inhibitors	Chemistry; Metallurgy	9	Active
US7652051B2	Heterocyclic compounds and methods of use	Chemistry; Metallurgy	8	Active
US7691858B2	Kinase inhibitors and methods of use thereof	Human Necessities	6	Active
US7456176B2	Benzotriazine inhibitors of kinases	Chemistry; Metallurgy	4	Active
US8084618B2	Heterocyclic compounds and methods of use	Chemistry; Metallurgy	3	Active
US8481536B2	Benzotriazine inhibitors of kinases	Chemistry; Metallurgy	0	Active
US8372971B2	Heterocyclic compounds and methods of use	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.